Publicaciones en las que colabora con Ana Fernández Santander (10)

2016

  1. Competencias en las prácticas clínicas en ciencias de la salud: guía de estrategias y recursos para su desarrollo y evaluación

    Editorial Médica Panamericana

2015

  1. Impacts of the glucuronidase genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on tamoxifen metabolism in breast cancer patients

    PLoS ONE, Vol. 10, Núm. 7

2013

  1. Relationship between Genotypes Sult1a2 and Cyp2d6 and Tamoxifen Metabolism in Breast Cancer Patients

    PLoS ONE, Vol. 8, Núm. 7

  2. Tamoxifen therapy in breast cancer: Do apolipoprotein E genotype and menopausal state affect plasma lipid changes induced by the drug?

    International Journal of Biological Markers, Vol. 28, Núm. 4

2012

  1. CYP2D6*4 allele and breast cancer risk: Is there any association?

    Clinical and Translational Oncology, Vol. 14, Núm. 2, pp. 157-159

2011

  1. Erratum: STR genetic diversity in a Mediterranean population from the south of the Iberian Peninsula (Annals of Human Biology (2010) 37:2 (254-267))

    Annals of Human Biology

2010

  1. CYP2D6 polymorphism screening in a selected population of Spain (La Alpujarra): No effect of geographical isolation

    Annals of Human Biology, Vol. 37, Núm. 2, pp. 267-273

  2. STR genetic diversity in a Mediterranean population from the south of the Iberian Peninsula

    Annals of Human Biology, Vol. 37, Núm. 2, pp. 253-266

2009

  1. Pharmacogenetics of acenocoumarol: CYP2C9 *2 and VKORCI c.-l 639G>A, 497C>G, 1173C>T, and 3730G>A variants influence drug dose in anticoagulated patients

    Thrombosis and Haemostasis, Vol. 101, Núm. 3, pp. 591-593

2008

  1. Identification of CYP2D6 null variants among long-stay, chronic psychiatric inpatients: Is it strictly necessary?

    Human Psychopharmacology, Vol. 23, Núm. 6, pp. 533-536